.jpg)
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for..
.jpg)
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of ‘Envlo’, a New Treatment for Diabet..
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration
.jpg)
Daewoong Pharmaceuticals Envlo to enter the global market in full swing... Filing for product licens..
‘Envlo’ of Daewoong Pharmaceutical, to be launched in the global markets... Entering the 1.54 billio..
.jpg)
Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Reven..
Daewoong Pharmaceutical begins the first administration of the Bersiporocin, new treatment for idiop..
Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic..
.jpg)
“Expected to change GERD drug market landscape” Daewoong Pharmaceutical submitted NDA for its global..
.jpg)
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims t..
.jpg)